Metraipolis › archive › dc_49941b468568

Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways — Europe PMC PMID:41944402

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41944402
DOI: 10.2478/aiht-2026-77-4026
License (as archived): solo-consultazione
Archived: 2026-11-03T15:56:37.483Z
SHA-256 of the archived text: e38efae2baea5f51d2383822fd4b4ddbdb74409567fde994b99b0d405fc5d789
Stable URL of this page: https://metraipolis.com/documento/dc_49941b468568

How to cite

Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways — Europe PMC PMID:41944402 — Europe PMC (en), https://europepmc.org/article/MED/41944402 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49941b468568 (Metraipolis archive dc_49941b468568, sha256 e38efae2baea5f51d2383822fd4b4ddbdb74409567fde994b99b0d405fc5d789)

BibTeX

@misc{dc49941b468568,
  title = {Forsythoside A attenuates metabolic dysfunction in type 2 diabetic mice by inhibiting the MAPK and activating the Nrf2 signalling pathways — Europe PMC PMID:41944402},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41944402},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49941b468568; sha256 e38efae2baea5f51d2383822fd4b4ddbdb74409567fde994b99b0d405fc5d789},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41944402. Agents can read the archived copy with the MCP tool read_document.